title: CRH-induced electrical activity and calcium signalling in pituitary corticotrophs.
abstract: Pituitary corticotroph cells generate repetitive action potentials and associated Ca2+ transients in response to the agonist corticotropin releasing hormone (CRH). There is indirect evidence suggesting that the agonist, by way of complex intracellular mechanisms, modulates the voltage sensitivity of the L-type Ca2+ channels embedded in the plasma membrane. We have previously constructed a Hodgkin-Huxley-type model of this process, which indicated that an increase in the L-type Ca2+ current is sufficient to generate repetitive action potentials (LeBeau et al. (1997). Biophys. J.73, 1263-1275). CRH is also believed to inhibit an inwardly rectifying K+ current. In this paper, we have found that a CRH-induced inhibition of the inwardly rectifying K+ current increases the model action potential firing frequency, [Ca2+]i transients and membrane excitability. This dual modulatory action of CRH on inward rectifier and voltage-gated Ca2+ channels better describes the observed CRH-induced effects. This structural alteration to the model along with parameter changes bring the model firing frequency in line with experimental data. We also show that the model exhibits experimentally observed bursting behaviour, where the depolarization spike is followed by small oscillations in the membrane potential.
authors.affiliation: Department of Mathematics and Statistics, University of Canterbury, Christchurch 1, New Zealand.
authors.forename: P R
authors.initials: PR
authors.lastname: Shorten
authors.forename: A B
authors.initials: AB
authors.lastname: Robson
authors.forename: A E
authors.initials: AE
authors.lastname: McKinnon
authors.forename: D J
authors.initials: DJ
authors.lastname: Wall
mesh_terms: D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D020746:Calcium Channels, L-Type / Q000187:drug effects*; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism; D008954:Models, Biological; D010903:Pituitary Gland, Anterior / Q000166:cytology / Q000378:metabolism*; D015221:Potassium Channels / Q000187:drug effects
chemical_list: D020746:Calcium Channels, L-Type; D015221:Potassium Channels; D003346:Corticotropin-Releasing Hormone; D017868:Cyclic AMP-Dependent Protein Kinases; D000252:Calcium-Transporting ATPases